Citation Tools

Download PDFPDF

1201 SGN-BB228 is a first-in-class CD228-targeted costimulatory antibody anticalin® bispecific delivering potent and conditional 4–1BB costimulation to tumor-specific T cells
Free

Download to a citation manager

Cite this article as:
Heiser R
1201 SGN-BB228 is a first-in-class CD228-targeted costimulatory antibody anticalin® bispecific delivering potent and conditional 4–1BB costimulation to tumor-specific T cells